Core Points - The company Inner Mongolia Furui Medical Technology Co., Ltd. (stock code: 300049) held its 15th meeting of the 8th Board of Directors on October 28, 2025, where two resolutions were passed unanimously [1] - The resolutions included the approval of the Q3 2025 report and amendments to the independent director working rules, aimed at enhancing corporate governance [1][2] Summary by Sections Board Meeting - The board meeting was conducted via electronic means with all five directors participating, resulting in a unanimous vote of 5 in favor, 0 against, and 0 abstentions [1] - The meeting was chaired by Chairman Wang Guan, and the notice was sent out on October 22 [1] Q3 2025 Report - The Q3 2025 report was disclosed on the same day as the board meeting, providing investors with the latest operational performance data [1] Independent Director Working Rules - The amendments to the independent director working rules were made to align with the latest revisions of the company's articles of association and comply with relevant laws and regulations [1] - The revised rules were also disclosed on the same platform, ensuring transparency [1][2]
福瑞股份第八届董事会第十五次会议决议出炉 全票通过三季度报告及独立董事工作细则修订案